Oxidative stress and neurodegeneration: where are we now?

被引:1990
|
作者
Halliwell, Barry [1 ]
机构
[1] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore, Singapore
关键词
free radical; hydroxyl radical; proteasome; protein aggregation; reactive oxygen species; superoxide;
D O I
10.1111/j.1471-4159.2006.03907.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The brain and nervous system are prone to oxidative stress, and are inadequately equipped with antioxidant defense systems to prevent 'ongoing' oxidative damage, let alone the extra oxidative damage imposed by the neurodegenerative diseases. Indeed, increased oxidative damage, mitochondrial dysfunction, accumulation of oxidized aggregated proteins, inflammation, and defects in protein clearance constitute complex intertwined pathologies that conspire to kill neurons. After a long lag period, therapeutic and other interventions based on a knowledge of redox biology are on the horizon for at least some of the neurodegenerative diseases.
引用
收藏
页码:1634 / 1658
页数:25
相关论文
共 50 条
  • [1] Measurements of Oxidative Stress - Where are we Now?
    Breusing, N.
    Grune, T.
    AKTUELLE ERNAHRUNGSMEDIZIN, 2008, 33 (03): : 106 - 115
  • [2] Therapies Targeting Oxidative Stress for Human Diseases: Where Are We Now?
    Nabavi, Seyed M.
    Daglia, Maria
    Sureda, Antoni
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2015, 16 (03) : 195 - 195
  • [3] Exercise stress echocardiography: Where are we now?
    Cotrim, Carlos Alberto
    Cafe, Hugo
    Joao, Isabel
    Cotrim, Nuno
    Guardado, Jorge
    Cordeiro, Pedro
    Cotrim, Hortense
    Baquero, Luis
    WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (02): : 64 - 82
  • [5] Mycotoxins and oxidative stress: where are we?
    da Silva, E. O.
    Bracarense, A. P. F. L.
    Oswald, I. P.
    WORLD MYCOTOXIN JOURNAL, 2018, 11 (01) : 113 - 133
  • [6] TRPM2 Cation Channels, Oxidative Stress and Neurological Diseases: Where Are We Now?
    Mustafa Nazıroğlu
    Neurochemical Research, 2011, 36 : 355 - 366
  • [7] TRPM2 Cation Channels, Oxidative Stress and Neurological Diseases: Where Are We Now?
    Naziroglu, Mustafa
    NEUROCHEMICAL RESEARCH, 2011, 36 (03) : 355 - 366
  • [8] Duloxetine as a treatment for stress incontinence—where are we now?
    Jonathan Duckett
    International Urogynecology Journal, 2008, 19 : 1 - 3
  • [9] Perceived Stress and Vascular Disease: Where Are We Now?
    Katsarou, Alexia L.
    Triposkiadis, Filippos
    Panagiotakos, Demosthenes
    ANGIOLOGY, 2013, 64 (07) : 529 - 534
  • [10] WHERE WERE WE AND WHERE ARE WE NOW
    VERKADE, JG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1984, 188 (AUG): : 49 - CHED